Prevtec Microbia Receives Market Authorization for Coliprotec(R) F4/F18 in Russia and CIS countries
MONTREAL, QUEBEC--(Marketwired - Oct 24, 2017) - Prevtec Microbia Inc. ("Prevtec") is pleased to announce that a Market Authorization was received for Russia, including all CIS countries, for its bivalent vaccine Coliprotec® F4/F18, a front line …